Yuko Taki

994 total citations
19 papers, 795 citations indexed

About

Yuko Taki is a scholar working on Molecular Biology, Rheumatology and Pharmacology. According to data from OpenAlex, Yuko Taki has authored 19 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Rheumatology and 4 papers in Pharmacology. Recurrent topics in Yuko Taki's work include Pharmacological Effects of Natural Compounds (4 papers), Ginkgo biloba and Cashew Applications (4 papers) and Folate and B Vitamins Research (4 papers). Yuko Taki is often cited by papers focused on Pharmacological Effects of Natural Compounds (4 papers), Ginkgo biloba and Cashew Applications (4 papers) and Folate and B Vitamins Research (4 papers). Yuko Taki collaborates with scholars based in Japan, India and United States. Yuko Taki's co-authors include Keizo Umegaki, Kaori Endoh, Yoko Sato, Shaw Watanabe, Kyoko Taku, Shizuo Yamada, Taichiro Muto, Koubun Yasuda, Tatsukata Kawagoe and Kenji Nakanishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Clinical Nutrition and Life Sciences.

In The Last Decade

Yuko Taki

19 papers receiving 757 citations

Peers

Countries citing papers authored by Yuko Taki

Since Specialization

Citations

This map shows the geographic impact of Yuko Taki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Taki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Taki more than expected).

Fields of papers citing papers by Yuko Taki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Taki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Taki. The network helps show where Yuko Taki may publish in the future.

Co-authorship network of co-authors of Yuko Taki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Taki. A scholar is included among the top collaborators of Yuko Taki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Taki. Yuko Taki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Pediatric Cystinuria Patient With Novel Mutation in SLC3A1 2019 ·Global Pediatric Health ·Yoshitaka Watanabe, Yoshifusa Abe, Shinichi Sakamoto, (unknown), Yuko Taki, Satoshi Hibino, Takashi Fukagai, Shuichiro Watanabe	4
2	Dietary Coleus forskohlii extract generates dose‐related hepatotoxicity in mice 2012 ·Journal of Applied Toxicology ·Nantiga Virgona, Yuko Taki, Shizuo Yamada, Keizo Umegaki	19
3	Hepatic cytochrome P450 mediates interaction between warfarin andColeus forskohliiextractin vivoandin vitro 2012 ·Journal of Pharmacy and Pharmacology ·(unknown), Tsuyoshi Chiba, Yoko Sato, Yuko Taki, Shizuo Yamada, Kazumasa Shinozuka, Masatsune Murata, Keizo Umegaki	21
4	Contribution of IL-33–activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice 2012 ·Proceedings of the National Academy of Sciences ·Koubun Yasuda, Taichiro Muto, Tatsukata Kawagoe, Makoto Matsumoto, Yuki Sasaki, Kazufumi Matsushita, Yuko Taki, Shizue Futatsugi‐Yumikura, Hiroko Tsutsui, Ken J. Ishii, Tomohiro Yoshimoto, Shizuo Akira, Kenji Nakanishi	256
5	Up-regulation of nicotinic and muscarinic receptor mRNA in rat bladder by repeated administration of nicotine in relation to the pharmacokinetics 2011 ·Life Sciences ·Noriyuki Yamamoto, Akira Yoshida, Yuko Taki, Satomi Onoue, Yoshiyuki Kagawa, Shizuo Yamada	7
6	Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice 2011 ·Phytomedicine ·Yuko Taki, (unknown), Shizuo Yamada, Kazumasa Shinozuka, Yōko Kubota, (unknown), Keizo Umegaki	37
7	Coleus forskohlii extract induces hepatic cytochrome P450 enzymes in mice 2011 ·Food and Chemical Toxicology ·Nantiga Virgona, (unknown), Yuko Yamazaki, Fumio Shimura, Tsuyoshi Chiba, Yuko Taki, Shizuo Yamada, Kazumasa Shinozuka, Masatsune Murata, Keizo Umegaki	22
8	Effects of Ginkgo biloba extract on the pharmacokinetics and pharmacodynamics of tolbutamide in protein-restricted rats 2011 ·Journal of Pharmacy and Pharmacology ·Yuko Taki, Eri Hagiwara, (unknown), Kazumasa Shinozuka, Keizo Umegaki, Shizuo Yamada	6
9	The N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and Pharmacokinetics 2010 ·Drug Metabolism and Disposition ·Shizuo Yamada, Yoshihiko Ito, Yuko Taki, (unknown), (unknown), (unknown), (unknown), (unknown), Ken‐Ichiro Yoshida	15
10	The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Bladder Selectivity Based on In Vivo Drug–Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder 2010 ·Journal of Pharmacological Sciences ·Akira Yoshida, (unknown), Shuji Maruyama, Yoshihiko Ito, Yuko Taki, Shizuo Yamada	25
11	Literature Search on the Interaction Between Warfarin and Vitamin K 2009 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·(unknown), Yoshihiko Ito, Yuko Taki, (unknown), Satomi Onoue, Yasuyuki Imai, Naoto Oku, Hiroshi Noguchi, Kunihiko Itoh, Hirokazu Kobayashi, Norio Ohashi, Toshinao Goda, Naohide Kinae, Keizo Umegaki, Hiroshi Watanabe, Shizuo Yamada	1
12	Time-Dependent Induction of Hepatic Cytochrome P450 Enzyme Activity and mRNA Expression by Bilobalide in Rats 2009 ·Journal of Pharmacological Sciences ·Yuko Taki, Yuko Yamazaki, Fumio Shimura, Shizuo Yamada, Keizo Umegaki	16
13	Effects of Repeated Morphine Treatment on the Antinociceptive Effects, Intestinal Absorption, and Efflux from Intestinal Epithelial Cells of Morphine 2009 ·Biological and Pharmaceutical Bulletin ·Takashi Okura, Tadahiro Ozawa, (unknown), Yuko Taki, (unknown), Yoshiyuki Kagawa, Yoshihisa Kato, Shizuo Yamada	16
14	Alteration of muscarinic and purinergic receptors in urinary bladder of rats with cyclophosphamide-induced interstitial cystitis 2008 ·Neuroscience Letters ·(unknown), (unknown), Yuko Taki, Yoshihisa Kato, Yoshihisa Nozawa, Yoshihiko Ito, Shizuo Yamada	23
15	Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials 2007 ·American Journal of Clinical Nutrition ·Kyoko Taku, Keizo Umegaki, Yoko Sato, Yuko Taki, Kaori Endoh, Shaw Watanabe	271
16	Low Folate Status Enhanced Benzene-Induced Cytogenetic Damage in Bone Marrow of Mice: A Relationship Between Dietary Intake and Tissue Levels of Folate 2007 ·Nutrition and Cancer ·Kaori Endoh, Masahiro Murakami, Tomomi Sugiyama, Yuko Taki, Keizo Umegaki	4
17	Bilobalide in ginkgo biloba extract is a major substance inducing hepatic CYPs 2007 ·Journal of Pharmacy and Pharmacology ·Keizo Umegaki, Yuko Taki, Kaori Endoh, (unknown), Hiroki Tanabe, Kazumasa Shinozuka, Tomomi Sugiyama	31
18	[Characteristics of the outbreaks of plant toxin food poisoning]. 2007 ·PubMed ·(unknown), Yuko Taki	1
19	Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2 1990 ·International Journal of Immunopharmacology ·Manabu Suzuki, (unknown), Yuko Taki, (unknown), Kiyoshi Miwa, Junji Hamuro	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact